logo

Delcath Systems Inc. (DCTH)



Trade DCTH now with
  Date
  Headline
5/15/2020 6:38:23 AM Delcath Systems Q1 Product Revenue $0.2 Mln Vs $0.1 Mln Last Year
5/15/2020 6:37:43 AM Delcath Systems Q1 Net Loss $7.9 Mln Vs Loss Of $7.9 Mln Last Year
10/18/2019 8:07:44 AM Delcath Systems Plans Reverse Stock Split Of Common Stock At Ratio Of 1-for-100
12/26/2018 8:02:32 AM Delcath Announces Commercial Licensing Agreement For CHEMOSAT
12/18/2018 8:05:09 AM Delcath Announces 4th Independent Safety Review Of Registration Trial Data For Metastatic Ocular Melanoma
10/15/2018 8:02:58 AM Delcath Expands Rollout Of Registration Trial In Metastatic Ocular Melanoma
9/26/2018 8:04:10 AM Delcath Systems Says Data From Prospective Phase 2 Study Of PHP Therapy Presented At CIRSE 2018
9/24/2018 8:03:11 AM Delcath Systems Says Data On PHP Therapy Presented At CIRSE 2018
8/21/2018 8:53:20 AM Delcath Says First Patient Enrolled In Amended Registration Trial In Ocular Melanoma Liver Metastases
8/20/2018 8:02:40 AM Delcath Says Patient Enrollment Begun Under Amended Protocol For Registration Trial In Ocular Melanoma Liver Metastases
8/17/2018 8:01:07 AM Delcath Issues Letter To Stockholders Providing Business Update
8/15/2018 8:02:16 AM Delcath Systems Posts Q2 Loss Per Share Of $7.26
8/6/2018 8:03:19 AM Delcath Systems Announces Subscription Period For Rights Offering